Strain of hantavirus nucleotide sequences thereof related probes, primers and vectors, and methods for detection
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsStuart T. Nichol, Christina F. Spiropoulou, Thomas G. Ksiazek, Pierre E. Rollin
Life of this patent
Estimating the term…
Abstract
The present invention relates to the discovery of a novel Hantavirus. In particular, the present invention relates to nucleic acids of the newly discovered virus and to nucleic acid reagents and antibodies for use in methods of detection and prevention of infection by the virus.
Claims17
A method of detecting the presence of a Hantavirus of the type designated Four Corners Virus in a sample, comprising reverse transcribing viral RNA in the sample to DNA followed by amplification of the DNA using a primer having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:8 and detecting the presence of an amplification product, whereby the presence of the amplification product is correlated with the presence of the Hantavirus in the sample.
A method of detecting the presence of a Hantavirus of the type designated Four Corners Virus in a sample, comprising reverse transcribing viral RNA in the sample to DNA followed by amplification of the DNA using a primer having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:9 and detecting the presence of an amplification product, whereby the presence of the amplification product is correlated with the presence of the Hantavirus in the sample.
A method of detecting the presence of a Hantavirus of the type designated Four Corners Virus in a sample, comprising reverse transcribing viral RNA in the sample to DNA followed by amplification of the DNA using primer having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:10 and detecting the presence of an amplification product, whereby the presence of the amplification product is correlated with the presence of the Hantavirus in the sample.
A method of detecting the presence of a Hantavirus of the type designated Four Corners Virus in a sample, comprising reverse transcribing viral RNA in the sample to DNA followed by amplification of the DNA using a primer having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:11 and detecting the presence of an amplification product, whereby the presence of the amplification product is correlated with the presence of the Hantavirus in the sample.
A method of detecting the presence of a Hantavirus of the type designated Four Corners Virus in a sample, comprising reverse transcribing viral RNA in the sample to DNA followed by amplification of the DNA using a primer having a nucleotide sequence which hybridizes to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5, or to a nucleotide sequence complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5, and which does not hybridize to nucleotide sequences present in Hantaan, Seoul, Puumala or Prosect Hill Hantaviruses, and detecting the presence of an amplification product, whereby the presence of the amplification product is correlated with the presence of the Hantavirus in the sample.
An isolated virus of the type designated Four Corners Virus, comprising a ribonucleic acid sequence fully complementary to nucleotide sequences set forth in the Sequence Listing as SEQ ID NO:1 and SEQ ID NO:2.
A nucleic acid comprising an isolated or purified RNA having a nucleotide sequence fully complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:1 or a purified DNA having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:1.
A nucleic acid comprising an isolated or purified RNA having a nucleotide sequence fully complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:2 or a purified DNA having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:2.
A nucleic acid comprising an isolated or purified RNA having a nucleotide sequence fully complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:3 or a purified DNA having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:3.
A nucleic acid comprising an isolated or purified RNA having a nucleotide sequence fully complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:4 or a purified DNA having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:4.
A nucleic acid comprising an isolated or purified RNA having a nucleotide sequence fully complementary to a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:5 or a purified DNA having a nucleotide sequence set forth in the Sequence Listing as SEQ ID NO:5.
An oligonuclcotide primer selected from the group consisting of the sequence set forth in the Sequence Listings as SEQ ID NO:8;
- SEQ ID NO:9;
- SEQ ID NO:
- 10 and SEQ ID NO:
- 11.
Dependencies are inferred from the claim text.